{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:01:14Z","timestamp":1767171674355,"version":"build-2238731810"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["no. ZR2020QH068"],"award-info":[{"award-number":["no. ZR2020QH068"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The dysfunction of RNA binding proteins (RBPs) is associated with various inflammation and cancer. The occurrence and progression of tumors are closely related to the abnormal expression of RBPs. There are few studies on RBPs in clear cell renal carcinoma (ccRCC), which allows us to explore the role of RBPs in ccRCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We obtained the gene expression data and clinical data of ccRCC from the Cancer Genome Atlas (TCGA) database and extracted all the information of RBPs. We performed differential expression analysis of RBPs. Risk model were constructed based on the differentially expressed RBPs (DERBPs). The expression levels of model markers were examined by reverse transcription-quantitative PCR (RT-qPCR) and analyzed for model-clinical relevance. Finally, we mapped the model's nomograms to predict the 1, 3 and 5-year survival rates for ccRCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that the five-year survival rate for the high-risk group was 40.2% (95% CI\u2009=\u20090.313\u2009~\u20090.518), while the five-year survival rate for the low-risk group was 84.3% (95% CI\u2009=\u20090.767\u2009~\u20090.926). The ROC curves (AUC\u2009=\u20090.748) also showed that our model had stable predictive power. Further RT-qPCR results were in accordance with our analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The results of the independent prognostic analysis showed that the model could be an independent prognostic factor for ccRCC. The results of the correlation analysis also demonstrated the good predictive ability of the model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, the 4-RBPs (EZH2, RPL22L1, RNASE2, U2AF1L4) risk model could be used as a prognostic indicator of ccRCC. Our study provides a possibility for predicting the survival of ccRCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-022-02801-y","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T05:07:57Z","timestamp":1651727277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenkai","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangli","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"2801_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.036","volume":"394","author":"K Wang","year":"2017","unstructured":"Wang K, Sun Y, Tao W, Fei X, Chang C. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1\/miR-195\u20135p\/29a-3p\/29c-3p\/CDC42 signals. Cancer Lett. 2017;394:1\u201312.","journal-title":"Cancer Lett"},{"issue":"5","key":"2801_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913\u201324.","journal-title":"Eur Urol"},{"issue":"1","key":"2801_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. Eur Urol. 2016;70(1):106\u201319.","journal-title":"Eur Urol"},{"issue":"12","key":"2801_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJM199609193351207","volume":"335","author":"RJ Motzer","year":"1996","unstructured":"Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335(12):865\u201375.","journal-title":"N Engl J Med"},{"issue":"1","key":"2801_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13062-016-0170-1","volume":"11","author":"S Dimitrieva","year":"2016","unstructured":"Dimitrieva S, Schlapbach R, Rehrauer H. Prognostic value of cross-omics screening for kidney clear cell renal cancer survival. Biol Direct. 2016;11(1):68.","journal-title":"Biol Direct"},{"key":"2801_CR6","doi-asserted-by":"crossref","unstructured":"Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, da Veiga Leprevost F, Reva B, Lih T-SM, Chang H-Y, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179(4):964\u201383.","DOI":"10.1016\/j.cell.2019.10.007"},{"issue":"12","key":"2801_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrg3813","volume":"15","author":"S Gerstberger","year":"2014","unstructured":"Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829\u201345.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2801_CR8","doi-asserted-by":"publisher","first-page":"e1520","DOI":"10.1002\/wrna.1520","volume":"10","author":"K Masuda","year":"2019","unstructured":"Masuda K, Kuwano Y. Diverse roles of RNA-binding proteins in cancer traits and their implications in gastrointestinal cancers. Wiley Interdiscip Rev RNA. 2019;10(3):e1520.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2801_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/528954","volume":"2015","author":"P Frisone","year":"2015","unstructured":"Frisone P, Pradella D, Di Matteo A, Belloni E, Ghigna C, Paronetto MP. SAM68: Signal Transduction and RNA Metabolism in Human Cancer. Biomed Res Int. 2015;2015: 528954.","journal-title":"Biomed Res Int"},{"issue":"6","key":"2801_CR10","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2018.04.031","volume":"23","author":"G Perron","year":"2018","unstructured":"Perron G, Jandaghi P, Solanki S, Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis AI, Arseneault M, Scelo G, Banks RE, et al. A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes. Cell Rep. 2018;23(6):1639\u201350.","journal-title":"Cell Rep"},{"issue":"18","key":"2801_CR11","first-page":"1380","volume":"38","author":"RG de Bruin","year":"2017","unstructured":"de Bruin RG, Rabelink TJ, van Zonneveld AJ, van der Veer EP. Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease. Eur Heart J. 2017;38(18):1380\u20138.","journal-title":"Eur Heart J"},{"issue":"7","key":"2801_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira B, Billaud M, Almeida R. RNA-Binding Proteins in Cancer: Old Players and New Actors. Trends Cancer. 2017;3(7):506\u201328.","journal-title":"Trends Cancer"},{"issue":"5","key":"2801_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.molmed.2018.03.008","volume":"24","author":"P Chatterji","year":"2018","unstructured":"Chatterji P, Rustgi AK. RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer. Trends Mol Med. 2018;24(5):490\u2013506.","journal-title":"Trends Mol Med"},{"issue":"2","key":"2801_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4251\/wjgo.v11.i2.71","volume":"11","author":"N Legrand","year":"2019","unstructured":"Legrand N, Dixon DA, Sobolewski C. AU-rich element-binding proteins in colorectal cancer. World J Gastrointest Oncol. 2019;11(2):71\u201390.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"2801_CR15","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.7150\/jca.27352","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen H, Liu J, Wang H, Cheng Q, Zhou C, Chen X, Ye F. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma. J Cancer. 2019;10(6):1580\u201392.","journal-title":"J Cancer"},{"issue":"8","key":"2801_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41419-019-1789-5","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zheng Z, Wu M, Zhang L, Wang J, Fu W, Xu N, Zhao Z, Lao Y, Xu H. The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2. Cell Death Dis. 2019;10(8):554.","journal-title":"Cell Death Dis"},{"issue":"17","key":"2801_CR17","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1093\/nar\/gkn434","volume":"36","author":"Y Lu","year":"2008","unstructured":"Lu Y, Rosenfeld R, Simon I, Nau GJ, Bar-Joseph Z. A probabilistic generative model for GO enrichment analysis. Nucleic Acids Res. 2008;36(17):e109.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2801_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2801_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2801_CR20","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.18632\/aging.101927","volume":"11","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen H, Chen Y, Qu L, Zhang E, Wang Z, Wu Y, Yang R, Mao R, Lu C, et al. HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif. Aging (Albany NY). 2019;11(8):2430\u201346.","journal-title":"Aging (Albany NY)"},{"issue":"1 Pt 2","key":"2801_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ygeno.2020.10.016","volume":"113","author":"X Hua","year":"2021","unstructured":"Hua X, Chen J, Ge S, Xiao H, Zhang L, Liang C. Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma. Genomics. 2021;113(1 Pt 2):850\u201360.","journal-title":"Genomics"},{"issue":"24","key":"2801_CR22","doi-asserted-by":"publisher","first-page":"25356","DOI":"10.18632\/aging.104137","volume":"12","author":"Y Xiang","year":"2020","unstructured":"Xiang Y, Zhou S, Hao J, Zhong C, Ma Q, Sun Z, Wei C. Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression. Aging (Albany NY). 2020;12(24):25356\u201372.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"2801_CR23","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.21037\/tcr-20-2393","volume":"9","author":"C-X Li","year":"2020","unstructured":"Li C-X, Chen J, Xu Z-G, Yiu W-K, Lin Y-T. The expression and prognostic value of RNA binding proteins in clear cell renal cell carcinoma. Transl Cancer Res. 2020;9(12):7415\u201331.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"2801_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijms.50704","volume":"18","author":"X Qin","year":"2021","unstructured":"Qin X, Liu Z, Yan K, Fang Z, Fan Y. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma. Int J Med Sci. 2021;18(4):953\u201363.","journal-title":"Int J Med Sci"},{"key":"2801_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.617872","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wei X, Feng H, Hu B, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, Wang S, et al. Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma. Front Genet. 2020;11: 617872.","journal-title":"Front Genet"},{"issue":"18","key":"2801_CR26","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1158\/0008-5472.CAN-16-3190","volume":"77","author":"P Marona","year":"2017","unstructured":"Marona P, G\u00f3rka J, Mazurek Z, Wilk W, Rys J, Majka M, Jura J, Miekus K. MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression. Cancer Res. 2017;77(18):4905\u201320.","journal-title":"Cancer Res"},{"issue":"1","key":"2801_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, Zheng L. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13(1):90.","journal-title":"J Hematol Oncol"},{"issue":"23","key":"2801_CR28","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.18632\/aging.102548","volume":"11","author":"B Wan","year":"2019","unstructured":"Wan B, Liu B, Huang Y, Yu G, Lv C. Prognostic value of immune-related genes in clear cell renal cell carcinoma. Aging (Albany NY). 2019;11(23):11474\u201389.","journal-title":"Aging (Albany NY)"},{"issue":"13","key":"2801_CR29","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-16-2020","volume":"23","author":"K Chen","year":"2017","unstructured":"Chen K, Xiao H, Zeng J, Yu G, Zhou H, Huang C, Yao W, Xiao W, Hu J, Guan W, et al. Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer. Clin Cancer Res. 2017;23(13):3428\u201341.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2801_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12094-014-1195-5","volume":"17","author":"ZQ Xu","year":"2015","unstructured":"Xu ZQ, Zhang L, Gao BS, Wan YG, Zhang XH, Chen B, Wang YT, Sun N, Fu YW. EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma. Clin Transl Oncol. 2015;17(1):41\u20139.","journal-title":"Clin Transl Oncol"},{"key":"2801_CR31","doi-asserted-by":"crossref","unstructured":"Chen Q, Li Z-L, Fu S-Q, Wang S-Y, Liu Y-T, Ma M, Yang X-R, Xie W-J, Gong B-B, Sun T. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma. Aging (Albany NY). 2021;13(3):3926\u201344.","DOI":"10.18632\/aging.202360"},{"issue":"11","key":"2801_CR32","doi-asserted-by":"publisher","first-page":"e0143659","DOI":"10.1371\/journal.pone.0143659","volume":"10","author":"N Wu","year":"2015","unstructured":"Wu N, Wei J, Wang Y, Yan J, Qin Y, Tong D, Pang B, Sun D, Sun H, Yu Y, et al. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition. PLoS ONE. 2015;10(11):e0143659.","journal-title":"PLoS ONE"},{"issue":"6","key":"2801_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12032-019-1283-z","volume":"36","author":"Z Liang","year":"2019","unstructured":"Liang Z, Mou Q, Pan Z, Zhang Q, Gao G, Cao Y, Gao Z, Pan Z, Feng W. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21. Med Oncol. 2019;36(6):56.","journal-title":"Med Oncol"},{"issue":"10","key":"2801_CR34","doi-asserted-by":"publisher","first-page":"e0222392","DOI":"10.1371\/journal.pone.0222392","volume":"14","author":"S Rao","year":"2019","unstructured":"Rao S, Peri S, Hoffmann J, Cai KQ, Harris B, Rhodes M, Connolly DC, Testa JR, Wiest DL. RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. PLoS ONE. 2019;14(10):e0222392.","journal-title":"PLoS ONE"},{"issue":"3","key":"2801_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molcel.2017.06.006","volume":"67","author":"M Preu\u00dfner","year":"2017","unstructured":"Preu\u00dfner M, Goldammer G, Neumann A, Haltenhof T, Rautenstrauch P, M\u00fcller-McNicoll M, Heyd F. Body Temperature Cycles Control Rhythmic Alternative Splicing in Mammals. Mol Cell. 2017;67(3):433\u201346.","journal-title":"Mol Cell"}],"updated-by":[{"DOI":"10.1186\/s12882-022-02867-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02801-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:47:01Z","timestamp":1659091621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02801-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2801"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02801-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12882-022-02867-8","URL":"https:\/\/doi.org\/10.1186\/s12882-022-02867-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Review Committee of the Affiliated Hospital of Qingdao University School of Medicine and informed consent was obtained from the patients. All the methods in this study were carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors in this study do not have any conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}